Name: Lexaria Bioscience Corp. (LEXX) Balance Sheet
Creator: FinSpry

Lexaria Bioscience Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Lexaria Bioscience Corp. (LEXX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Aug 2024	Aug 2023	Aug 2022	Aug 2021
Current Assets
Cash and Cash Equivalents	1.80	6.50	1.35	5.81	10.92
Short-Term Investments	0.17	0.06	0.13	0.35	0.83
Cash & Short-Term Investments	1.97	6.56	1.48	6.16	11.75
Accounts Receivable	0.37	0.15	0.13	0.08	0.34
Inventory	0.00	0.00	0.00	0.04	0.03
Other Current Assets	1.13	1.19	0.55	0.58	0.32
Total Current Assets	3.47	7.90	2.15	6.98	12.44
Non-Current Assets
Property, Plant & Equipment (Net)	0.33	0.39	0.42	0.37	0.46
Intangible Assets	0.31	0.52	0.46	0.49	0.36
Other Non-Current Assets	0.06	0.06	0.05	0.00	0.00
Total Non-Current Assets	0.71	0.97	0.93	0.86	0.00
Total Assets	4.18	8.87	3.08	7.83	13.27
Current Liabilities
Accounts Payable	1.37	1.06	0.23	0.12	0.06
Short-Term Debt	0.03	0.00	0.00	0.00	0.00
Accrued Liabilities	0.89	0.69	0.01	0.03	0.05
Deferred Revenue	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	0.10	0.00	0.00	0.00	0.00
Total Current Liabilities	1.49	1.10	0.27	0.19	0.15
Non-Current Liabilities
Long-Term Debt	0.08	0.11	0.14	0.01	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.08	0.11	0.14	0.01	0.00
Total Liabilities	1.57	1.21	0.40	0.20	0.20
Stockholders' Equity
Common Stock	0.02	0.02	0.01	0.01	0.01
Retained Earnings	-63.46	-51.56	-45.76	-39.10	-31.83
Accumulated Other Comprehensive Income	-0.07	-0.02	0.00	0.00	0.00
Additional Paid-in Capital	66.50	59.60	48.80	47.04	0.00
Minority Interest	-0.39	-0.38	-0.36	-0.32	0.00
Shares Outstanding	19.56	15.81	8.09	5.95	0.00
Total Stockholders' Equity	2.99	8.04	2.68	7.95	13.06
Total Liabilities & Equity	4.18	8.87	3.08	7.83	0.00